Trust Five Year Strategy Launched

Posted 19th December 2018

The Clatterbridge Cancer Centre has unveiled its five year strategy which sets out its vision for the future.

The strategy is the culmination of an extensive programme of engagement over the last twelve months with staff and stake

The strategy is based on six key themes:holders to identify the objectives and priorities for the Trust.

  • Transforming Cancer Care through delivery of new clinical model
  • Developing our outstanding staff
  • Investing in research and innovation
  • Collaborative system leadership
  • Be Enterprising
  • Maintaining Excellent Quality, Operational and Financial Performance

The Clatterbridge Cancer Centre has a strong reputation for high quality care and always improving services for the benefit of its patients.

This next phase of development will build on our existing platform of excellent care delivered in state of the art facilities, which will reflect the expertise of our staff and the needs of our patients. An increased focus on research will ensure we remain at the cutting edge of treatment and care now and into the future.

Ambitions for the future outlined in the strategy document include:

  • Providing more of our services closer to – or in – patients’ homes, as well as continually improving patients’ experience of care.
  • Delivering our new flagship hospital in the centre of Liverpool
  • Attracting, retaining and developing the best people by ensuring The Clatterbridge Cancer Centre is an excellent place to work.
  • Supporting our clinicians to continue to work at the forefront of care and treatment, through increased research and innovation

Dr Liz Bishop, Chief Executive, said: “The Clatterbridge Cancer Centre is an exceptional organisation because of our people and our patients.

“Our strategy makes clear what we want to achieve over the next five years with our partners; placing the needs of our patients at the very heart of our organisation to ensure that we can continue to provide the best possible care and outcomes for cancer patients long into the future.”

You can read the Strategic Direction 2018 – 2022 here